Emergent BioSolutions (EBS) Competitor Comparison
We are evaluating the key criteria listed to compare Emergent BioSolutions (EBS) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
36 / 54Gross Profits
17 / 39Total Revenue
12 / 50EBITDA
39 / 53Free Cashflow
10 / 54Quick Ratio
50 / 54Earnings per Share
52 / 54Dividend yield
0 / 5Total Cash
29 / 54Performance 3 years
35 / 54Performance 5 years
39 / 54Performance 10 years
26 / 54Linearity 3 years
37 / 54Linearity 5 years
28 / 54Linearity 10 years
13 / 54Total Rank
35 / 54Dividend Rank
17 / 54Valuation Rank
31 / 54Piotroski Rank
43 / 54Muliplier Rank
40 / 54Market Capitalization - EBS ranking 36 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.